AR
KDNY

Advisory Research’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Advisory Research’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,927
Closed -$716K – 509
2023
Q1 		$716K Sell
30,927
-174
-0.6% -$4.03K 0.12% 206
2022
Q4 		$815K Buy
31,101
+2,207
+8% +$57.8K 0.08% 186
2022
Q3 		$568K Buy
+28,894
New +$568K 0.06% 224